Las Vegas, NV -- (SBWIRE) -- 09/26/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: NII Holdings Inc (NASDAQ:NIHD), Amarin Corporation plc (ADR) (NASDAQ:AMRN), AuRico Gold Inc (NYSE:AUQ), Elite Pharmaceuticals Inc (OTCBB: ELTP)
NII Holdings Inc (NASDAQ:NIHD) showed no change on above-normal volume of 3.81M shares. The stock settled at $6.18 after floating in a range of $6.15 to $6.30. Its latest price has reached market capitalization of $1.07 billion. Its 52-week range has been $4.11 to $9.82. NII Holdings, Inc., through its subsidiaries, provides wireless communication services under the Nextel brand name to businesses and individuals in Mexico, Brazil, Argentina, Peru, and Chile.
Can Investors Bet on NIHD after this News update? Find out in this Research Report
Amarin Corporation plc (ADR) (NASDAQ:AMRN) traded up on a volume of 3.64 million, lower its standard daily volume. Shares have gained 0.39% to $6.43. Over the last twelve months, the stock has lost/51.94% and faced a worst price of $5.12. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases.
For How Long AMRN’s Gloss will Attract Investors? Find out via this report
AuRico Gold Inc (NYSE:AUQ) settled -1.01% lower at $3.91 on below -normal volume of 3.52M shares during the last trading day. The stock has its 12-month high at $8.53 and 52-week low price was $8.53. It traded in a range of $3.89 to $4.06 during the last trading day.
Will AUQ Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Elite Pharmaceuticals Inc (OTCBB: ELTP) was up on high volume, trading at a volume of 3.80M versus its average daily volume of 3.36 million shares. At $0.128, the stock has attained market capitalization of 51.64 million. Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals.
Will ELTP Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)